Abstract
Although not guideline recommended, studies suggest 50% of locoregional breast cancer patients undergo systemic imaging during follow-up, prompting its inclusion as a Choosing Wisely measure of potential overuse. Most studies rely on administrative data that cannot delineate scan intent (prompted by signs/symptoms vs. asymptomatic surveillance). This is a critical gap as intent is the only way to distinguish overuse from appropriate care. Our aim was to assess surveillance systemic imaging post-breast cancer treatment in a national sample accounting for scan intent. A stage-stratified random sample of 10 women with stage II-III breast cancer in 2006-2007 was selected from each of 1217 Commission on Cancer-accredited facilities, for a total of 10,838 patients. Registrars abstracted scan type (computed tomography [CT], non-breast magnetic resonance imaging, bone scan, positron emission tomography/CT) and intent (cancer-related vs. not, asymptomatic surveillance vs. not) from medical records for 5 years post-diagnosis. Data were merged with each patient's corresponding National Cancer Database record, containing sociodemographic and tumor/treatment information. Of 10,838 women, 30% had one or more, and 12% had two or more, systemi...Continue Reading
References
May 25, 1994·JAMA : the Journal of the American Medical Association
Jan 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Liberati
May 11, 1999·JAMA : the Journal of the American Medical Association·D PalliP Pacini
Dec 30, 2003·Journal of Surgical Oncology·David P WinchesterR Scott Jones
Oct 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James L KhatcheressianUNKNOWN American Society of Clinical Oncology
Jan 10, 2008·Annals of Surgical Oncology·Karl Y BilimoriaClifford Y Ko
Aug 6, 2008·Journal of General Internal Medicine·L Miriam DickinsonLisa Meredith
Nov 3, 2010·Journal of Oncology Practice·Eva GrunfeldRahim Moineddin
Sep 29, 2011·Breast Cancer Research and Treatment·K S PanageasD Schrag
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lowell E SchnipperDana S Wollins
May 16, 2012·Surgical Oncology Clinics of North America·Richelle T WilliamsDavid P Winchester
Jun 16, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelElizabeth Ward
Nov 3, 2012·Breast Cancer Research and Treatment·Sandra M E GeurtsVivianne C G Tjan-Heijnen
Nov 7, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James L KhatcheressianUNKNOWN American Society of Clinical Oncology
Oct 10, 2013·Cancer·Erin E HahnPatricia A Ganz
Feb 8, 2014·Annals of Surgical Oncology·Haejin InDavid P Winchester
Nov 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rachel J D CossettiKaren A Gelmon
Dec 10, 2015·Cancer·Erin E HahnMichael K Gould
Jan 21, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marco ColleoniAron Goldhirsch
Citations
Jul 19, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·Randy C MilesJanie M Lee
May 30, 2020·BMJ Quality & Safety·Ora PaltielRachel Bar-Shalom
Sep 22, 2018·Annals of Surgical Oncology·Natalia S Partain, Kelly K Hunt
Nov 7, 2020·Breast Cancer Research and Treatment·Hely ShahMark Clemons